AGREEⅡ日本語訳 - Mindsガイドラインライブラリ

1 AGREEII EBM Japan Council for Quality Health Care Department of EBM and Guidelines I NSTRUMENT The AGREE Next Steps Consortium U PDATE September 2013 May 2009 ii AGREEII AGREE AGREEII AGREE AGREEII The AGREE Research Trust, May 2009.

2 The AGREE Research Trust, September 2013. Brouwers M, Kho ME, Browman GP, Cluzeau F, feder G, Fervers B, Hanna S, Makarski J on behalf of the AGREE Next Steps Consortium. AGREE II: Advancing guideline development, reporting and evaluation in healthcare. Can Med Assoc J. Dec 2010, 182:E839-842; doi: AGREEII the Canadian Institutes of Health Research (FRN77822) AGREE AGREEII AGREE AGREE 10th Year Anniversary: 2003 2013 iii Dr.

3 Melissa C. Brouwers Principal Investigator, AGREE Next Steps Consortium McMaster University, Hamilton, Ontario, Canada Consortium Members: Dr. GP. Browman, British Columbia Cancer Agency, Vancouver Island, Canada Dr. JS. Burgers, Dutch Institute for Healthcare Improvement CBO, The Netherlands Dr. F. Cluzeau, Chair of AGREE Research Trust; St. George s Hospital Medical School, London, UK Dr. D. Davis, Association of American Medical Colleges, Washington, DC, USA Dr. G. Feder, University of Bristol, UK Dr. B. Fervers, Cancer et Environement, Centre L on B rard, France Dr.

4 I. Graham, Canadian Institutes of Health Research, Ottawa, Ontario, Canada Dr. J. Grimshaw, Ottawa Health Research Institute, Ontario, Canada Dr. SE. Hanna, McMaster University, Hamilton, Ontario,Canada Ms. ME. Kho, McMaster University, Hamilton, Ontario Canada Dr. P. Littlejohns, National Institute for Health and Clinical Excellence, London, UK Ms. J. Makarski, McMaster University, Hamilton, Ontario, Canada Dr. L. Zitzelsberger, Canadian Partnership Against Cancer, Ottawa, Ontario, Canada AGREE NEXT STEPS CONSORTIUM NOTICE: AGREE II Original Public Release and Publication Date: 2009/2010 AGREEII Update: September 2013 Please see the Update section, at the end of the Introduction, following the References section iv I I.

5 1II AGREEII ..4 III ..4II AGREEII ..9I AGREEII ..10II AGREEII ..10 III ..11IV AGREEII ..12V ..13VI a 1 ..14b 2 ..18c 3 ..22d 4 .. 31e 5 ..35 6 ..40 ..43 III AGREEII ..1I 1 ..2II 2 ..3 III 3 ..4IV 4 ..7V 5 ..8VI 6 ..10 VII ..11 1 I i AGREEII 1 2.

6 3 4-6 7-9 The Appraisal of Guidelines for REsearch & Evaluation AGREE 10 AGREE AGREE AGREEII 11 AGREEII AGREEII AGREE ii AGREE AGREE 2003 AGREE 10 AGREE AGREE 10 AGREE 6 23 AGREE AGREE 100 AGREE AGREE I 2 AGREE AGREE Next Steps

7 Consortium Consortium Consortium AGREEII AGREE 6 23 AGREE 23 1 AGREE AGREEII AGREE AGREEII AGREEII 1 2 3 4 5 6 7 19 8 7 9 8 9 body of evidence 10 11 AGREE 1 2 3 3 AGREEII 12 13 14

8 15 16 17 18 19 19 18 20 21 22 23 AGREE 4 5 6 4 i AGREEII AGREE AGREEII AGREEII AGREEII ii AGREEII AGREEII

9 I AGREE AGREE ART AGREE 2004 ART AGREEII AGREE enterprise AGREE AGREE AGREEII AGREEII AGREEII AGREE AGREE AGREE AGREE Next Steps Consortium AGREE II AGREEII III 5 ii AGREE II AGREE Next Steps Consortium (2009).

10 The AGREE II Instrument [Electronic version]. Retrieved <Month, Day, Year>, from . iii AGREE II AGREEII iv AGREE II AGREE II: Advancing guideline development, reporting and evaluation in healthcare. Parallel publications in progress. v AGREE AGREE Collaboration. Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project. Qual Saf Health Care. 2003 Feb;12(1):18-23. 1. Woolf SH, Grol R, Hutchinson A, Eccles M, Grimshaw J.